Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension

Area Omogenea di Cardiologia e Medicina, Ospedale R. Silvestrini, Perugia, Italy. verdec@tin.it

OBJECTIVES: We tested the prognostic value of a new electrocardiographic (ECG) method (Perugia score) for diagnosis of left ventricular hypertrophy (LVH) in essential hypertension and compared it with five standard methods (Cornell voltage, Framingham criterion, Romhilt-Estes point score, left ventricular strain, Sokolow-Lyon voltage). BACKGROUND: Several standard ECG methods for assessment of LVH are used in the clinical setting, but a comparative prognostic assessment is lacking. METHODS: A total of 1,717 white hypertensive subjects (mean age 52 years; 51% men) were prospectively followed up for up to 10 years (mean 3.3). RESULTS: At entry, the prevalence of LVH was 17.8% (Perugia score), 9.1% (Cornell), 3.9% (Framingham), 5.2% (Romhilt-Estes), 6.4% (strain) and 13.1% (Sokolow-Lyon). During follow-up there were 159 major cardiovascular morbid events (33 fatal). The event rate was higher in the subjects with than in those without LVH (all p < 0.001) according to all methods except the Sokolow-Lyon method. By multivariate analysis, an independent association between LVH and cardiovascular disease risk was maintained by the Perugia score (hazard ratio [HR] 2.04, 95% confidence interval [CI] 1.5 to 2.8) and the Framingham (HR 1.91, 95% CI 1.1 to 3.2), Romhilt-Estes (HR 2.63, 95% CI 1.7 to 4.1) and strain methods (HR 2.11, 95% CI 1.4 to 3.2). The Perugia score showed the highest population-attributable risk for cardiovascular events, accounting for 15.6% of all cases, whereas the Framingham, Romhilt-Estes and strain methods accounted for 3.0%, 7.4% and 6.8% of all events, respectively. LVH diagnosed by the Perugia score was also associated with an increased risk of cardiovascular mortality (HR 4.21, 95% CI 2.1 to 8.7), with a population-attributable risk of 37.0%. CONCLUSIONS: The Perugia score carried the highest population-attributable risk for cardiovascular morbidity and mortality compared with classic methods for detection of LVH. Traditional interpretation of standard electrocardiography maintains an important role for cardiovascular risk stratification in essential hypertension.

This article has been cited by other articles:

				M. R. Zile, S. M. DeSantis, C. F. Baicu, R. E. Stroud, S. B. Thompson, C. D. McClure, S. M. Mehurg, and F. G. Spinale Plasma Biomarkers That Reflect Determinants of Matrix Composition Identify the Presence of Left Ventricular Hypertrophy and Diastolic Heart Failure Circ Heart Fail, May 1, 2011; 4(3): 246 - 256. [Abstract] [Full Text] [PDF]

				P. M. Okin, L. Oikarinen, M. Viitasalo, L. Toivonen, S. E. Kjeldsen, M. S. Nieminen, J. M. Edelman, B. Dahlof, R. B. Devereux, and for the LIFE study Investigators Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE study Eur J Heart Fail, April 1, 2011; 13(4): 384 - 391. [Abstract] [Full Text] [PDF]

				P. Verdecchia, P. Sleight, G. Mancia, R. Fagard, B. Trimarco, R. E. Schmieder, J.-H. Kim, G. Jennings, P. Jansky, J.-H. Chen, et al. Effects of Telmisartan, Ramipril, and Their Combination on Left Ventricular Hypertrophy in Individuals at High Vascular Risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease Circulation, October 6, 2009; 120(14): 1380 - 1389. [Abstract] [Full Text] [PDF]

				P. M. Okin, L. Oikarinen, M. Viitasalo, L. Toivonen, S. E. Kjeldsen, M. S. Nieminen, J. M. Edelman, B. Dahlof, R. B. Devereux, and for the LIFE Study Investigators Prognostic Value of Changes in the Electrocardiographic Strain Pattern During Antihypertensive Treatment: The Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE) Circulation, April 14, 2009; 119(14): 1883 - 1891. [Abstract] [Full Text] [PDF]

				J. Ishikawa, S. Ishikawa, T. Kabutoya, T. Gotoh, K. Kayaba, J. E. Schwartz, T. G. Pickering, K. Shimada, K. Kario, and for the Jichi Medical School Cohort Study Investig Cornell Product Left Ventricular Hypertrophy in Electrocardiogram and the Risk of Stroke in a General Population Hypertension, January 1, 2009; 53(1): 28 - 34. [Abstract] [Full Text] [PDF]

				G. Montalvo, F. Avanzini, M. Anselmi, R. Prandi, S. Ibarra, M. Marquez, D. Armani, J.-M. Moreira, C. Caicedo, M. C. Roncaglioni, et al. Diagnostic evaluation of people with hypertension in low income country: cohort study of "essential" method of risk stratification BMJ, September 19, 2008; 337(sep19_1): a1387 - a1387. [Abstract] [Full Text] [PDF]

				P. M. Okin, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, L. H. Lindholm, B. Dahlof, and for the LIFE Study Investigators In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study Hypertension, November 1, 2007; 50(5): 984 - 990. [Abstract] [Full Text] [PDF]

				D. Pewsner, P. Juni, M. Egger, M. Battaglia, J. Sundstrom, and L. M Bachmann Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review BMJ, October 6, 2007; 335(7622): 711 - 711. [Abstract] [Full Text] [PDF]

				N M Hawkins, D Wang, J J V McMurray, M A Pfeffer, K Swedberg, C B Granger, S Yusuf, S J Pocock, J Ostergren, E L Michelson, et al. Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme Heart, January 1, 2007; 93(1): 59 - 64. [Abstract] [Full Text] [PDF]

				G. Salles, C. Cardoso, A. R. Nogueira, K. Bloch, and E. Muxfeldt Importance of the Electrocardiographic Strain Pattern in Patients With Resistant Hypertension Hypertension, September 1, 2006; 48(3): 437 - 442. [Abstract] [Full Text] [PDF]

				G. Schillaci, M. Pirro, T. Ronti, F. Gemelli, G. Pucci, S. Innocente, C. Porcellati, and E. Mannarino Prognostic Impact of Prolonged Ventricular Repolarization in Hypertension. Arch Intern Med, April 24, 2006; 166(8): 909 - 913. [Abstract] [Full Text] [PDF]

				P. M. Okin, R. B. Devereux, E. Gerdts, S. M. Snapinn, K. E. Harris, S. Jern, S. E. Kjeldsen, S. Julius, J. M. Edelman, L. H. Lindholm, et al. Impact of Diabetes Mellitus on Regression of Electrocardiographic Left Ventricular Hypertrophy and the Prediction of Outcome During Antihypertensive Therapy: The Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study Circulation, March 28, 2006; 113(12): 1588 - 1596. [Abstract] [Full Text] [PDF]

				P. M. Okin, R. B. Devereux, M. S. Nieminen, S. Jern, L. Oikarinen, M. Viitasalo, L. Toivonen, S. E. Kjeldsen, B. Dahlof, and for the LIFE Study Investigators Electrocardiographic Strain Pattern and Prediction of New-Onset Congestive Heart Failure in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study Circulation, January 3, 2006; 113(1): 67 - 73. [Abstract] [Full Text] [PDF]

				P. Verdecchia, F. Angeli, R. Gattobigio, M. Sardone, and C. Porcellati Asymptomatic Left Ventricular Systolic Dysfunction in Essential Hypertension: Prevalence, Determinants, and Prognostic Value Hypertension, March 1, 2005; 45(3): 412 - 418. [Abstract] [Full Text] [PDF]

				P. M. Okin, R. B. Devereux, S. Jern, S. E. Kjeldsen, S. Julius, M. S. Nieminen, S. Snapinn, K. E. Harris, P. Aurup, J. M. Edelman, et al. Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Treatment and the Prediction of Major Cardiovascular Events JAMA, November 17, 2004; 292(19): 2343 - 2349. [Abstract] [Full Text] [PDF]

				R. H. Fagard, J. A. Staessen, L. Thijs, H. Celis, W. H. Birkenhager, C. J. Bulpitt, P. W. de Leeuw, G. Leonetti, C. Sarti, J. Tuomilehto, et al. Prognostic Significance of Electrocardiographic Voltages and Their Serial Changes in Elderly With Systolic Hypertension Hypertension, October 1, 2004; 44(4): 459 - 464. [Abstract] [Full Text] [PDF]

				P. M. Okin, R. B. Devereux, M. S. Nieminen, S. Jern, L. Oikarinen, M. Viitasalo, L. Toivonen, S. E. Kjeldsen, S. Julius, S. Snapinn, et al. Electrocardiographic Strain Pattern and Prediction of Cardiovascular Morbidity and Mortality in Hypertensive Patients Hypertension, July 1, 2004; 44(1): 48 - 54. [Abstract] [Full Text] [PDF]

				G. B. J. Mancini, B. Dahlof, and J. Diez Surrogate Markers for Cardiovascular Disease: Structural Markers Circulation, June 29, 2004; 109(25_suppl_1): IV-22 - IV-30. [Full Text] [PDF]

				G. Schillaci, M. Pirro, G. Vaudo, F. Gemelli, S. Marchesi, C. Porcellati, and E. Mannarino Prognostic value of the metabolic syndrome in essential hypertension J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1817 - 1822. [Abstract] [Full Text] [PDF]

				P. Verdecchia, G. Reboldi, F. Angeli, C. Borgioni, R. Gattobigio, L. Filippucci, S. Norgiolini, C. Bracco, and C. Porcellati Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects Hypertension, May 1, 2004; 43(5): 963 - 969. [Abstract] [Full Text] [PDF]

				P. M. Okin, M. J. Roman, E. T. Lee, J. M. Galloway, B. V. Howard, and R. B. Devereux Combined Echocardiographic Left Ventricular Hypertrophy and Electrocardiographic ST Depression Improve Prediction of Mortality in American Indians: The Strong Heart Study Hypertension, April 1, 2004; 43(4): 769 - 774. [Abstract] [Full Text] [PDF]

				P. M. Okin, R. B. Devereux, S. Jern, S. E. Kjeldsen, S. Julius, M. S. Nieminen, S. Snapinn, K. E. Harris, P. Aurup, J. M. Edelman, et al. Regression of Electrocardiographic Left Ventricular Hypertrophy by Losartan Versus Atenolol: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study Circulation, August 12, 2003; 108(6): 684 - 690. [Abstract] [Full Text] [PDF]

				G. Selvetella, A. Notte, A. Maffei, V. Calistri, V. Scamardella, G. Frati, B. Trimarco, C. Colonnese, and G. Lembo Left Ventricular Hypertrophy Is Associated With Asymptomatic Cerebral Damage in Hypertensive Patients Stroke, July 1, 2003; 34(7): 1766 - 1770. [Abstract] [Full Text] [PDF]

				P. Verdecchia, G. Reboldi, R. Gattobigio, M. Bentivoglio, C. Borgioni, F. Angeli, E. Carluccio, M. G. Sardone, and C. Porcellati Atrial Fibrillation in Hypertension: Predictors and Outcome Hypertension, February 1, 2003; 41(2): 218 - 223. [Abstract] [Full Text] [PDF]

				P. M. Okin, R. B. Devereux, R. R. Fabsitz, E. T. Lee, J. M. Galloway, and B. V. Howard Quantitative assessment of electrocardiographic strain predicts increased left ventricular mass: the strong heart study J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1395 - 1400. [Abstract] [Full Text] [PDF]

				P. Verdecchia, G. Reboldi, C. Porcellati, G. Schillaci, S. Pede, M. Bentivoglio, F. Angeli, S. Norgiolini, and G. Ambrosio Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects J. Am. Coll. Cardiol., March 6, 2002; 39(5): 878 - 885. [Abstract] [Full Text] [PDF]

				E. Bossone, G. Paciocco, D. Iarussi, A. Agretto, A. Iacono, B. W. Gillespie, and M. Rubenfire The Prognostic Role of the ECG in Primary Pulmonary Hypertension Chest, February 1, 2002; 121(2): 513 - 518. [Abstract] [Full Text] [PDF]

				P. Verdecchia, G. Carini, A. Circo, E. Dovellini, E. Giovannini, M. Lombardo, P. Solinas, M. Gorini, A. P. Maggioni, and the MAVI Study Group Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1829 - 1835. [Abstract] [Full Text] [PDF]

				P. Verdecchia, C. Porcellati, G. Reboldi, R. Gattobigio, C. Borgioni, T. A. Pearson, and G. Ambrosio Left Ventricular Hypertrophy as an Independent Predictor of Acute Cerebrovascular Events in Essential Hypertension Circulation, October 23, 2001; 104(17): 2039 - 2044. [Abstract] [Full Text] [PDF]

				P. M. Okin, R. B. Devereux, M. S. Nieminen, S. Jern, L. Oikarinen, M. Viitasalo, L. Toivonen, S. E. Kjeldsen, S. Julius, B. Dahlof, et al. Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study J. Am. Coll. Cardiol., August 1, 2001; 38(2): 514 - 520. [Abstract] [Full Text] [PDF]

				P. Verdecchia, G. Schillaci, G. Reboldi, S. S. Franklin, and C. Porcellati Different Prognostic Impact of 24-Hour Mean Blood Pressure and Pulse Pressure on Stroke and Coronary Artery Disease in Essential Hypertension Circulation, May 29, 2001; 103(21): 2579 - 2584. [Abstract] [Full Text] [PDF]

				J. Sundstrom, L. Lind, J. Arnlov, B. Zethelius, B. Andren, and H. O. Lithell Echocardiographic and Electrocardiographic Diagnoses of Left Ventricular Hypertrophy Predict Mortality Independently of Each Other in a Population of Elderly Men Circulation, May 15, 2001; 103(19): 2346 - 2351. [Abstract] [Full Text] [PDF]

				G. Schillaci, G. Reboldi, and P. Verdecchia High-Normal Serum Creatinine Concentration Is a Predictor of Cardiovascular Risk in Essential Hypertension Arch Intern Med, March 26, 2001; 161(6): 886 - 891. [Abstract] [Full Text] [PDF]

				P. Verdecchia, G. Schillaci, G. Reboldi, F. Santeusanio, C. Porcellati, and P. Brunetti Relation Between Serum Uric Acid and Risk of Cardiovascular Disease in Essential Hypertension : The PIUMA Study Hypertension, December 1, 2000; 36(6): 1072 - 1078. [Abstract] [Full Text] [PDF]

				P. M. Okin, R. B. Devereux, S. Jern, S. E. Kjeldsen, S. Julius, and B. Dahlof Baseline Characteristics in Relation to Electrocardiographic Left Ventricular Hypertrophy in Hypertensive Patients : The Losartan Intervention For Endpoint Reduction (LIFE) in Hypertension Study Hypertension, November 1, 2000; 36(5): 766 - 773. [Abstract] [Full Text] [PDF]

				P. M. Cury, M. d. L. Higuchi, P. S. Gutierrez, L. F. P. Moreira, E. A. Bocchi, N. A.G. Stolf, and A. D. Jatene Autopsy findings in early and late postoperative death after partial left ventriculectomy Ann. Thorac. Surg., March 1, 2000; 69(3): 769 - 773. [Abstract] [Full Text] [PDF]

				P. M. Okin, S. Jern, R. B. Devereux, S. E. Kjeldsen, B. Dahlof, and f. t. L. S. Group Effect of Obesity on Electrocardiographic Left Ventricular Hypertrophy in Hypertensive Patients : The Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study Hypertension, January 1, 2000; 35(1): 13 - 18. [Abstract] [Full Text] [PDF]

				P. Verdecchia, G. Schillaci, C. Borgioni, A. Ciucci, S. Pede, and C. Porcellati Ambulatory Pulse Pressure : A Potent Predictor of Total Cardiovascular Risk in Hypertension Hypertension, December 1, 1998; 32(6): 983 - 988. [Abstract] [Full Text] [PDF]